中国高与低PCV13覆盖率地区鼻咽部肺炎链球菌携带菌株抗菌药物非敏感性的不同模式
2022年在中国海南省4个地区2333名5岁以下健康儿童中分离737株肺炎链球菌,比较不同PCV13接种史及地区覆盖率下血清型携带与抗菌药物非敏感性。接种儿童疫苗血清型6B、6A、23F携带率显著低于未接种儿童;高覆盖率地区菌株对青霉素、头孢呋辛、红霉素、阿奇霉素、克林霉素及复方磺胺甲噁唑的非敏感性较低且多重耐药较少。
要点
- 接种PCV13儿童疫苗血清型6B携带率7.0% vs 未接种2.7%(P<0.01)。
- 分离菌株对红霉素非敏感性92.3%,82.9%为多重耐药。
- 高覆盖率地区菌株对青霉素等抗生素非敏感性及多重耐药低于低覆盖率地区。
核心结论
- 鼻咽部肺炎链球菌携带菌株对常用临床抗生素高度耐药,PCV13接种显著降低疫苗血清型携带和抗菌药物非敏感性。
- 作者认为,肺炎球菌结合疫苗的广泛使用可能对鼻咽部携带和抗菌药物非敏感性产生实质性影响。
研究设计与样本
- 2022年在中国海南省海口、万宁、白沙和琼中4个地区招募2333名5岁以下健康儿童,分离737株肺炎链球菌。
- 进行血清分型和抗菌药物敏感性试验,按个体PCV13接种史和当地疫苗接种覆盖率分为4组:高覆盖率地区接种组(VH)和未接种组(NVH),低覆盖率地区接种组(VL)和未接种组(NVL)。
- 采用描述性统计和逻辑回归分析评估疫苗影响。
主要发现
- 接种PCV13儿童疫苗血清型携带率显著低于未接种儿童:6B为7.0% vs 2.7%(P<0.01),6A为4.2% vs 1.2%(P<0.05),23F为2.2% vs 0.3%(P<0.05)。
- 分离菌株对红霉素、阿奇霉素、克林霉素、四环素、青霉素和头孢呋辛的非敏感性率分别为92.3%、87.5%、81.2%、91.2%、38.9%和64.7%。
- 82.9%的分离菌株为多重耐药(MDR),疫苗血清型中尤为突出(92.4%)。
- 高PCV13覆盖率地区分离菌株对青霉素、头孢呋辛、红霉素、阿奇霉素、克林霉素和复方磺胺甲噁唑的非敏感性较低,且多重耐药少于低覆盖率地区分离菌株。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The impact of pneumococcal conjugate vaccines (PCVs) on antimicrobial resistance (AMR) in Streptococcus pneumoniae (Spn) among Chinese children remains inadequately characterized. Evidence is also limited on the interaction between vaccination coverage and regional disparities in AMR patterns. This study aims to assess the impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on nasopharyngeal carriage of Spn and antimicrobial nonsusceptibility to commonly used antibiotics among healthy children under five years of age in China. METHODS: In 2022, 737 pneumococci were isolated from 2333 healthy children recruited in 4 areas (Haikou, Wanning, Baisha, and Qiongzhong) in Hainan Province, China. Serotyping and antimicrobial susceptibility tests were performed. Participants were divided into 4 groups based on individual PCV13 vaccination history and the local vaccination coverage rates: vaccinated and unvaccinated groups in the high-coverage area (group VH & NVH), and vaccinated and unvaccinated groups in the low-coverage areas (group VL & NVL). Descriptive statistics and logistic regression analysis were used to assess the vaccine impacts. RESULTS: PCV13-vaccinated children exhibited significantly lower carriage rates of vaccine-type serotypes (VTs) compared to unvaccinated children: 6B (7.0 % vs. 2.7 %, P < 0.01), 6A (4.2 % vs. 1.2 %, P < 0.05), and 23F (2.2 % vs. 0.3 %, P < 0.05). The non-susceptibility rates to erythromycin, azithromycin, clindamycin, tetracycline, penicillin, and cefuroxime were 92.3 %, 87.5 %, 81.2 %, 91.2 %, 38.9 % and 64.7 %, respectively, resulting in 82.9 % of isolates being multidrug-resistant (MDR), especially to VTs (92.4 %). Isolates from the high PCV13 coverage area were less resistant to penicillin, cefuroxime, erythromycin, azithromycin, clindamycin and SXT, and were less MDR than isolates from the low PCV13 coverage areas. CONCLUSIONS: Nasopharyngeal carriage of Spn was highly resistant to common clinical antibiotics. PCV13 vaccination significantly decreased VTs carriage and antimicrobial nonsusceptibility. These results suggest that the widespread use of PCVs is likely to substantially affect NP carriage and antimicrobial nonsusceptibility.
引用
- Wang J, Zhao W, Bai S, et al. Different patterns of antimicrobial non-susceptibility of the nasopharyngeal carriage of Streptococcus pneumoniae in areas with high and low levels of PCV13 coverage. Vaccine. 2025. PMID: 40618622. doi:10.1016/j.vaccine.2025.127455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。